Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders

Compounds of formula (I) and (II), wherein the substituents are as defined in the specification, and the compounds 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione and 3-(4-amino-1-oxo-1,3 -dihydroisoindol-2-yl)-piperidine-2,6-dione are useful in the treatment of adenosine deaminase defici...

Full description

Saved in:
Bibliographic Details
Main Authors XU, WEIMING, CORRAL, LAURA G
Format Patent
LanguageEnglish
Published 24.12.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of formula (I) and (II), wherein the substituents are as defined in the specification, and the compounds 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione and 3-(4-amino-1-oxo-1,3 -dihydroisoindol-2-yl)-piperidine-2,6-dione are useful in the treatment of adenosine deaminase deficiency, antibody deficiency with normal or elevated Igs, ataxia-tenlangiectasia, bare lymphocyte syndrome, common variable immunodeficiency, Ig deficiency with hyper-IgM, Ig heavy chain deletions, IgA deficiency, immunodeficiency with thymoma, reticular dysgenesis, Nezelof syndrome, selective IgG subclass deficiency, transient hypogammaglobulinemia of infancy, Wistcott-Aldrich syndrome, X-linked agammaglobulinemia, or X-linked severe combined immunodeficiency.
Bibliography:Application Number: NZ20050555886